SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'MER'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1GHM_A_CEDA1_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 6 / 12 | SER A 70LYS A 73SER A 130ASN A 132LYS A 234GLY A 236 | MER A 301 (-1.3A)MER A 301 ( 3.8A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.2A)MER A 301 (-3.0A) | 0.39A | 1ghmA-3bfgA:38.4 | 1ghmA-3bfgA:34.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1GHM_A_CEDA1_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | SER A 70LYS A 73SER A 130ASN A 132LYS A 234GLY A 236 | MER A 401 (-1.3A)MER A 401 ( 4.4A)MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-3.0A)MER A 401 (-3.6A) | 0.37A | 1ghmA-4ev4A:37.5 | 1ghmA-4ev4A:31.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GHM_A_CEDA1_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 7 / 12 | ALA A 120SER A 121LYS A 124SER A 176ASN A 178LYS A 282GLY A 284 | MER A 400 (-3.5A)MER A 400 (-1.3A)MER A 400 ( 4.1A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.0A)MER A 400 (-3.1A) | 0.38A | 1ghmA-4pprA:19.6 | 1ghmA-4pprA:20.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1H7X_A_URFA1033_1 (DIHYDROPYRIMIDINEDEHYDROGENASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 4 / 6 | ASN A 136ASN A 170ASN A 104THR A 103 | NoneMER A 301 (-2.6A)MER A 301 ( 4.1A)None | 1.25A | 1h7xA-3bfgA:undetectable | 1h7xA-3bfgA:13.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1H7X_B_URFB1033_1 (DIHYDROPYRIMIDINEDEHYDROGENASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 4 / 6 | ASN A 136ASN A 170ASN A 104THR A 103 | NoneMER A 301 (-2.6A)MER A 301 ( 4.1A)None | 1.22A | 1h7xB-3bfgA:undetectable | 1h7xB-3bfgA:13.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1H7X_C_URFC1033_1 (DIHYDROPYRIMIDINEDEHYDROGENASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 4 / 6 | ASN A 136ASN A 170ASN A 104THR A 103 | NoneMER A 301 (-2.6A)MER A 301 ( 4.1A)None | 1.24A | 1h7xC-3bfgA:undetectable | 1h7xC-3bfgA:13.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1H7X_D_URFD1033_1 (DIHYDROPYRIMIDINEDEHYDROGENASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 4 / 6 | ASN A 136ASN A 170ASN A 104THR A 103 | NoneMER A 301 (-2.6A)MER A 301 ( 4.1A)None | 1.22A | 1h7xD-3bfgA:undetectable | 1h7xD-3bfgA:13.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I2W_A_CFXA1300_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 10 / 12 | SER A 70LYS A 73ASN A 104SER A 130ASN A 132GLU A 166THR A 216LYS A 234GLY A 236ALA A 237 | MER A 301 (-1.3A)MER A 301 ( 3.8A)MER A 301 ( 4.1A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.3A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.0A)MER A 301 (-4.2A) | 0.48A | 1i2wA-3bfgA:41.5 | 1i2wA-3bfgA:42.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I2W_A_CFXA1300_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 7 / 12 | SER A 70LYS A 73SER A 130ASN A 132THR A 216LYS A 234GLY A 236 | MER A 401 (-1.3A)MER A 401 ( 4.4A)MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.6A) | 0.40A | 1i2wA-4ev4A:40.5 | 1i2wA-4ev4A:45.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1I2W_A_CFXA1300_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 7 / 12 | ALA A 120SER A 121LYS A 124SER A 176ASN A 178LYS A 282GLY A 284 | MER A 400 (-3.5A)MER A 400 (-1.3A)MER A 400 ( 4.1A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.0A)MER A 400 (-3.1A) | 0.40A | 1i2wA-4pprA:20.3 | 1i2wA-4pprA:23.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I2W_B_CFXB2300_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 9 / 12 | SER A 70LYS A 73ASN A 104SER A 130ASN A 132GLU A 166THR A 216GLY A 236ALA A 237 | MER A 301 (-1.3A)MER A 301 ( 3.8A)MER A 301 ( 4.1A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.3A)MER A 301 (-3.6A)MER A 301 (-3.0A)MER A 301 (-4.2A) | 0.50A | 1i2wB-3bfgA:41.7 | 1i2wB-3bfgA:42.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I2W_B_CFXB2300_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | SER A 70LYS A 73SER A 130ASN A 132GLY A 236ARG A 220 | MER A 401 (-1.3A)MER A 401 ( 4.4A)MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-3.6A)MER A 401 ( 3.9A) | 1.19A | 1i2wB-4ev4A:40.8 | 1i2wB-4ev4A:45.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I2W_B_CFXB2300_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | SER A 70LYS A 73SER A 130ASN A 132THR A 216GLY A 236 | MER A 401 (-1.3A)MER A 401 ( 4.4A)MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 ( 3.9A)MER A 401 (-3.6A) | 0.43A | 1i2wB-4ev4A:40.8 | 1i2wB-4ev4A:45.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1I2W_B_CFXB2300_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 6 / 12 | ALA A 120SER A 121LYS A 124SER A 176ASN A 178GLY A 284 | MER A 400 (-3.5A)MER A 400 (-1.3A)MER A 400 ( 4.1A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.1A) | 0.32A | 1i2wB-4pprA:20.4 | 1i2wB-4pprA:23.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JIN_A_KTNA801_1 (CYTOCHROME P450107A1) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 5 / 11 | ALA A 237VAL A 278LEU A 279ALA A 280ALA A 223 | MER A 301 (-4.2A)NoneNoneNoneNone | 1.08A | 1jinA-3bfgA:undetectable | 1jinA-3bfgA:21.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YMX_A_CFXA1001_1 (BETA-LACTAMASECTX-M-9) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 11 / 12 | SER A 70LYS A 73ASN A 104SER A 130ASN A 132GLU A 166ASN A 170THR A 216LYS A 234GLY A 236ASP A 240 | MER A 301 (-1.3A)MER A 301 ( 3.8A)MER A 301 ( 4.1A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.3A)MER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.0A)None | 0.39A | 1ymxA-3bfgA:46.9 | 1ymxA-3bfgA:75.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YMX_A_CFXA1001_1 (BETA-LACTAMASECTX-M-9) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 8 / 12 | SER A 70LYS A 73SER A 130ASN A 132ASN A 170THR A 216LYS A 234GLY A 236 | MER A 401 (-1.3A)MER A 401 ( 4.4A)MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.6A) | 0.56A | 1ymxA-4ev4A:42.4 | 1ymxA-4ev4A:48.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YMX_A_CFXA1001_1 (BETA-LACTAMASECTX-M-9) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 6 / 12 | SER A 121LYS A 124SER A 176ASN A 178LYS A 282GLY A 284 | MER A 400 (-1.3A)MER A 400 ( 4.1A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.0A)MER A 400 (-3.1A) | 0.28A | 1ymxA-4pprA:20.1 | 1ymxA-4pprA:23.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YMX_B_CFXB1002_1 (BETA-LACTAMASECTX-M-9) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 10 / 12 | SER A 70LYS A 73ASN A 104SER A 130ASN A 132GLU A 166ASN A 170LYS A 234GLY A 236ASP A 240 | MER A 301 (-1.3A)MER A 301 ( 3.8A)MER A 301 ( 4.1A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.3A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.0A)None | 0.39A | 1ymxB-3bfgA:47.1 | 1ymxB-3bfgA:75.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YMX_B_CFXB1002_1 (BETA-LACTAMASECTX-M-9) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 7 / 12 | SER A 70LYS A 73SER A 130ASN A 132ASN A 170LYS A 234GLY A 236 | MER A 401 (-1.3A)MER A 401 ( 4.4A)MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 (-3.0A)MER A 401 (-3.6A) | 0.54A | 1ymxB-4ev4A:42.4 | 1ymxB-4ev4A:48.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YMX_B_CFXB1002_1 (BETA-LACTAMASECTX-M-9) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 6 / 12 | SER A 121LYS A 124SER A 176ASN A 178LYS A 282GLY A 284 | MER A 400 (-1.3A)MER A 400 ( 4.1A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.0A)MER A 400 (-3.1A) | 0.27A | 1ymxB-4pprA:20.0 | 1ymxB-4pprA:23.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZW9_B_SAMB801_1 (LEUCINE CARBOXYLMETHYLTRANSFERASE 2) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 4 / 8 | ILE A 247SER A 130TYR A 264SER A 72 | NoneMER A 301 (-2.6A)NoneNone | 0.95A | 2zw9B-3bfgA:undetectable | 2zw9B-3bfgA:18.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HLW_A_CE3A301_1 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 8 / 12 | LYS A 73ASN A 104SER A 130ASN A 132ASN A 170THR A 216LYS A 234GLY A 236 | MER A 301 ( 3.8A)MER A 301 ( 4.1A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.0A) | 0.44A | 3hlwA-3bfgA:46.5 | 3hlwA-3bfgA:74.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HLW_A_CE3A301_1 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 7 / 12 | LYS A 73SER A 130ASN A 132ASN A 170THR A 216LYS A 234GLY A 236 | MER A 401 ( 4.4A)MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.6A) | 0.58A | 3hlwA-4ev4A:42.3 | 3hlwA-4ev4A:48.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HLW_A_CE3A301_1 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 5 / 12 | LYS A 124SER A 176ASN A 178LYS A 282GLY A 284 | MER A 400 ( 4.1A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.0A)MER A 400 (-3.1A) | 0.42A | 3hlwA-4pprA:20.2 | 3hlwA-4pprA:22.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HLW_B_CE3B302_1 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 8 / 12 | ASN A 104SER A 130ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236 | MER A 301 ( 4.1A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A) | 0.43A | 3hlwB-3bfgA:46.9 | 3hlwB-3bfgA:74.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HLW_B_CE3B302_1 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 7 / 12 | SER A 130ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236 | MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A) | 0.50A | 3hlwB-4ev4A:42.4 | 3hlwB-4ev4A:48.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HLW_B_CE3B302_1 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | SER A 130ASN A 132THR A 216LYS A 234THR A 235GLY A 239 | MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)None | 0.82A | 3hlwB-4ev4A:42.4 | 3hlwB-4ev4A:48.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HLW_B_CE3B302_1 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 5 / 12 | SER A 176ASN A 178LYS A 282THR A 283GLY A 284 | MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.0A)MER A 400 (-3.6A)MER A 400 (-3.1A) | 0.31A | 3hlwB-4pprA:20.1 | 3hlwB-4pprA:22.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HUO_A_PNNA300_0 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 8 / 12 | LYS A 73ASN A 104ASN A 132ASN A 170LYS A 234THR A 235GLY A 236ASP A 240 | MER A 301 ( 3.8A)MER A 301 ( 4.1A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A)None | 0.50A | 3huoA-3bfgA:46.7 | 3huoA-3bfgA:74.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HUO_A_PNNA300_0 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | LYS A 73ASN A 132ASN A 170LYS A 234THR A 235GLY A 236 | MER A 401 ( 4.4A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A) | 0.47A | 3huoA-4ev4A:42.3 | 3huoA-4ev4A:48.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HUO_A_PNNA300_0 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 5 / 12 | LYS A 124ASN A 178LYS A 282THR A 283GLY A 284 | MER A 400 ( 4.1A)MER A 400 (-3.0A)MER A 400 (-3.0A)MER A 400 (-3.6A)MER A 400 (-3.1A) | 0.38A | 3huoA-4pprA:20.0 | 3huoA-4pprA:22.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HUO_B_PNNB301_0 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 7 / 12 | LYS A 73ASN A 104ASN A 132ASN A 170LYS A 234GLY A 236ASP A 240 | MER A 301 ( 3.8A)MER A 301 ( 4.1A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.0A)None | 0.44A | 3huoB-3bfgA:46.8 | 3huoB-3bfgA:74.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HUO_B_PNNB301_0 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 5 / 12 | LYS A 73ASN A 132ASN A 170LYS A 234GLY A 236 | MER A 401 ( 4.4A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 (-3.0A)MER A 401 (-3.6A) | 0.46A | 3huoB-4ev4A:42.2 | 3huoB-4ev4A:48.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MZE_A_CFXA364_1 (D-ALANYL-D-ALANINECARBOXYPEPTIDASEDACA) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | SER A 70LYS A 73ASN A 132THR A 235GLY A 236ARG A 220 | MER A 401 (-1.3A)MER A 401 ( 4.4A)MER A 401 (-3.2A)MER A 401 (-3.5A)MER A 401 (-3.6A)MER A 401 ( 3.9A) | 0.77A | 3mzeA-4ev4A:21.8 | 3mzeA-4ev4A:23.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MZE_A_CFXA364_1 (D-ALANYL-D-ALANINECARBOXYPEPTIDASEDACA) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 7 / 12 | ALA A 120SER A 121LYS A 124ASN A 178LEU A 218THR A 283GLY A 284 | MER A 400 (-3.5A)MER A 400 (-1.3A)MER A 400 ( 4.1A)MER A 400 (-3.0A)MER A 400 (-4.2A)MER A 400 (-3.6A)MER A 400 (-3.1A) | 0.45A | 3mzeA-4pprA:31.8 | 3mzeA-4pprA:23.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MZE_A_CFXA364_1 (D-ALANYL-D-ALANINECARBOXYPEPTIDASEDACA) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 7 / 12 | ALA A 120SER A 121LYS A 124ASN A 178THR A 283GLY A 284THR A 286 | MER A 400 (-3.5A)MER A 400 (-1.3A)MER A 400 ( 4.1A)MER A 400 (-3.0A)MER A 400 (-3.6A)MER A 400 (-3.1A)MER A 400 ( 4.9A) | 0.59A | 3mzeA-4pprA:31.8 | 3mzeA-4pprA:23.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NY4_A_SMXA308_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 8 / 12 | SER A 70SER A 130ASN A 170THR A 216LYS A 234THR A 235GLY A 236ASP A 240 | MER A 301 (-1.3A)MER A 301 (-2.6A)MER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A)None | 0.69A | 3ny4A-3bfgA:40.5 | 3ny4A-3bfgA:46.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NY4_A_SMXA308_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 9 / 12 | SER A 70SER A 130ASN A 170THR A 216ARG A 220LYS A 234THR A 235GLY A 236THR A 237 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A)MER A 401 (-3.7A) | 0.58A | 3ny4A-4ev4A:39.0 | 3ny4A-4ev4A:43.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 8 / 12 | LYS A 73ASN A 104SER A 130ASN A 132ASN A 170LYS A 234GLY A 236ASP A 240 | MER A 301 ( 3.8A)MER A 301 ( 4.1A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.0A)None | 0.53A | 3q07A-3bfgA:46.5 | 3q07A-3bfgA:74.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 6 / 12 | LYS A 73SER A 130THR A 171ASN A 170LYS A 234GLY A 236 | MER A 301 ( 3.8A)MER A 301 (-2.6A)NoneMER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.0A) | 1.44A | 3q07A-3bfgA:46.5 | 3q07A-3bfgA:74.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | LYS A 73SER A 130ASN A 132ASN A 170LYS A 234GLY A 236 | MER A 401 ( 4.4A)MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 (-3.0A)MER A 401 (-3.6A) | 0.44A | 3q07A-4ev4A:42.2 | 3q07A-4ev4A:48.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 5 / 12 | LYS A 124SER A 176ASN A 178LYS A 282GLY A 284 | MER A 400 ( 4.1A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.0A)MER A 400 (-3.1A) | 0.43A | 3q07A-4pprA:20.0 | 3q07A-4pprA:22.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 8 / 12 | LYS A 73ASN A 104SER A 130ASN A 132ASN A 170LYS A 234GLY A 236ASP A 240 | MER A 301 ( 3.8A)MER A 301 ( 4.1A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.0A)None | 0.43A | 3q07B-3bfgA:46.8 | 3q07B-3bfgA:74.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 6 / 12 | LYS A 73SER A 130THR A 171ASN A 170LYS A 234GLY A 236 | MER A 301 ( 3.8A)MER A 301 (-2.6A)NoneMER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.0A) | 1.47A | 3q07B-3bfgA:46.8 | 3q07B-3bfgA:74.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | LYS A 73SER A 130ASN A 132ASN A 170LYS A 234GLY A 236 | MER A 401 ( 4.4A)MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 (-3.0A)MER A 401 (-3.6A) | 0.56A | 3q07B-4ev4A:39.4 | 3q07B-4ev4A:48.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 5 / 12 | LYS A 124SER A 176ASN A 178LYS A 282GLY A 284 | MER A 400 ( 4.1A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.0A)MER A 400 (-3.1A) | 0.41A | 3q07B-4pprA:19.8 | 3q07B-4pprA:22.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SH8_A_CEDA1_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 8 / 12 | SER A 70ASN A 104SER A 130ASN A 132LYS A 234THR A 235GLY A 236ALA A 237 | MER A 301 (-1.3A)MER A 301 ( 4.1A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A)MER A 301 (-4.2A) | 0.49A | 3sh8A-3bfgA:40.2 | 3sh8A-3bfgA:43.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SH8_A_CEDA1_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | SER A 70SER A 130ASN A 132LYS A 234THR A 235GLY A 236 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A) | 0.48A | 3sh8A-4ev4A:39.6 | 3sh8A-4ev4A:43.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SH8_A_CEDA1_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 7 / 12 | ALA A 120SER A 121SER A 176ASN A 178LYS A 282THR A 283GLY A 284 | MER A 400 (-3.5A)MER A 400 (-1.3A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.0A)MER A 400 (-3.6A)MER A 400 (-3.1A) | 0.31A | 3sh8A-4pprA:20.4 | 3sh8A-4pprA:23.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SH8_B_CEDB1_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 8 / 12 | SER A 70LYS A 73ASN A 104SER A 130ASN A 132LYS A 234GLY A 236ALA A 237 | MER A 301 (-1.3A)MER A 301 ( 3.8A)MER A 301 ( 4.1A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.2A)MER A 301 (-3.0A)MER A 301 (-4.2A) | 0.55A | 3sh8B-3bfgA:40.0 | 3sh8B-3bfgA:43.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SH8_B_CEDB1_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | SER A 70LYS A 73SER A 130ASN A 132LYS A 234GLY A 236 | MER A 401 (-1.3A)MER A 401 ( 4.4A)MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-3.0A)MER A 401 (-3.6A) | 0.48A | 3sh8B-4ev4A:39.3 | 3sh8B-4ev4A:43.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SH8_B_CEDB1_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 7 / 12 | ALA A 120SER A 121LYS A 124SER A 176ASN A 178LYS A 282GLY A 284 | MER A 400 (-3.5A)MER A 400 (-1.3A)MER A 400 ( 4.1A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.0A)MER A 400 (-3.1A) | 0.44A | 3sh8B-4pprA:20.2 | 3sh8B-4pprA:23.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 8 / 12 | LYS A 73SER A 130ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236 | MER A 301 ( 3.8A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A) | 0.49A | 4euzA-3bfgA:42.7 | 4euzA-3bfgA:51.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 11 / 12 | LYS A 73HIS A 105SER A 130ASN A 132LEU A 167ASN A 170THR A 216LYS A 234THR A 235GLY A 236THR A 237 | MER A 401 ( 4.4A)MER A 401 ( 3.7A)MER A 401 (-2.8A)MER A 401 (-3.2A)NoneMER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A)MER A 401 (-3.7A) | 0.57A | 4euzA-4ev4A:50.8 | 4euzA-4ev4A:99.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 6 / 12 | LYS A 124SER A 176ASN A 178LYS A 282THR A 283GLY A 284 | MER A 400 ( 4.1A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.0A)MER A 400 (-3.6A)MER A 400 (-3.1A) | 0.47A | 4euzA-4pprA:19.7 | 4euzA-4pprA:23.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 6 / 12 | SER A 176ASN A 178LEU A 218LYS A 282THR A 283GLY A 284 | MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-4.2A)MER A 400 (-3.0A)MER A 400 (-3.6A)MER A 400 (-3.1A) | 0.79A | 4euzA-4pprA:19.7 | 4euzA-4pprA:23.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 6 / 10 | SER A 130ASN A 132LYS A 234THR A 235GLY A 236ALA A 237 | MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A)MER A 301 (-4.2A) | 0.52A | 4fh2A-3bfgA:36.0 | 4fh2A-3bfgA:40.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 5 / 10 | SER A 130ASN A 132LYS A 234THR A 235GLY A 236 | MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A) | 0.56A | 4fh2A-4ev4A:35.2 | 4fh2A-4ev4A:37.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N9K_A_CEDA301_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 9 / 12 | SER A 70ASN A 104SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236ALA A 237 | MER A 301 (-1.3A)MER A 301 ( 4.1A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A)MER A 301 (-4.2A) | 0.47A | 4n9kA-3bfgA:42.1 | 4n9kA-3bfgA:42.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N9K_A_CEDA301_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 7 / 12 | SER A 70SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A) | 0.40A | 4n9kA-4ev4A:41.1 | 4n9kA-4ev4A:43.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N9K_A_CEDA301_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 7 / 12 | ALA A 120SER A 121SER A 176ASN A 178LYS A 282THR A 283GLY A 284 | MER A 400 (-3.5A)MER A 400 (-1.3A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.0A)MER A 400 (-3.6A)MER A 400 (-3.1A) | 0.28A | 4n9kA-4pprA:20.5 | 4n9kA-4pprA:24.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N9K_B_CEDB301_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 9 / 12 | SER A 70ASN A 104SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236ALA A 237 | MER A 301 (-1.3A)MER A 301 ( 4.1A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A)MER A 301 (-4.2A) | 0.50A | 4n9kB-3bfgA:41.9 | 4n9kB-3bfgA:42.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N9K_B_CEDB301_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 7 / 12 | SER A 70SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A) | 0.43A | 4n9kB-4ev4A:40.9 | 4n9kB-4ev4A:43.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N9K_B_CEDB301_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 7 / 12 | ALA A 120SER A 121SER A 176ASN A 178LYS A 282THR A 283GLY A 284 | MER A 400 (-3.5A)MER A 400 (-1.3A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.0A)MER A 400 (-3.6A)MER A 400 (-3.1A) | 0.34A | 4n9kB-4pprA:20.6 | 4n9kB-4pprA:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PGF_B_ADNB502_2 (ADENOSYLHOMOCYSTEINASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 4 / 5 | THR A 103THR A 133THR A 76ASN A 170 | NoneNoneNoneMER A 301 (-2.6A) | 1.36A | 4pgfB-3bfgA:undetectable | 4pgfB-3bfgA:20.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM5_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 7 / 12 | ASN A 104ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236 | MER A 301 ( 4.1A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A) | 0.43A | 4pm5A-3bfgA:46.9 | 4pm5A-3bfgA:75.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM5_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 7 / 12 | ASN A 104SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236 | MER A 301 ( 4.1A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A) | 0.66A | 4pm5A-3bfgA:46.9 | 4pm5A-3bfgA:75.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM5_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236 | MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A) | 0.46A | 4pm5A-4ev4A:42.1 | 4pm5A-4ev4A:48.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM5_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236 | MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A) | 0.75A | 4pm5A-4ev4A:42.1 | 4pm5A-4ev4A:48.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM7_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 8 / 12 | LYS A 73ASN A 104ASN A 132ASN A 170THR A 216LYS A 234GLY A 236ALA A 237 | MER A 301 ( 3.8A)MER A 301 ( 4.1A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.0A)MER A 301 (-4.2A) | 0.51A | 4pm7A-3bfgA:46.8 | 4pm7A-3bfgA:75.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM7_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 8 / 12 | LYS A 73ASN A 104SER A 130ASN A 132ASN A 170LYS A 234GLY A 236ALA A 237 | MER A 301 ( 3.8A)MER A 301 ( 4.1A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.0A)MER A 301 (-4.2A) | 0.68A | 4pm7A-3bfgA:46.8 | 4pm7A-3bfgA:75.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM7_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | LYS A 73ASN A 132ASN A 170THR A 216LYS A 234GLY A 236 | MER A 401 ( 4.4A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.6A) | 0.58A | 4pm7A-4ev4A:42.0 | 4pm7A-4ev4A:48.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM9_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 8 / 12 | ASN A 104ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236ALA A 237 | MER A 301 ( 4.1A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A)MER A 301 (-4.2A) | 0.49A | 4pm9A-3bfgA:47.0 | 4pm9A-3bfgA:75.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM9_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 7 / 12 | ASN A 104SER A 130ASN A 132ASN A 170LYS A 234GLY A 236ALA A 237 | MER A 301 ( 4.1A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.0A)MER A 301 (-4.2A) | 0.69A | 4pm9A-3bfgA:47.0 | 4pm9A-3bfgA:75.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM9_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236 | MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A) | 0.47A | 4pm9A-4ev4A:41.9 | 4pm9A-4ev4A:48.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM9_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236 | MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A) | 0.75A | 4pm9A-4ev4A:41.9 | 4pm9A-4ev4A:48.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZXI_A_GLYA1402_0 (TYROCIDINESYNTHETASE 3) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 4 / 7 | ASP A 246ILE A 221GLY A 232THR A 235 | NoneNoneNoneMER A 401 (-3.5A) | 1.16A | 4zxiA-4ev4A:undetectable | 4zxiA-4ev4A:12.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHY_A_CEDA301_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 7 / 12 | SER A 70SER A 130ASN A 132ASN A 170LYS A 234GLY A 236ALA A 237 | MER A 301 (-1.3A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.0A)MER A 301 (-4.2A) | 0.47A | 5ghyA-3bfgA:41.7 | 5ghyA-3bfgA:42.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHY_A_CEDA301_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | SER A 70SER A 130ASN A 132ASN A 170LYS A 234GLY A 236 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 (-3.0A)MER A 401 (-3.6A) | 0.50A | 5ghyA-4ev4A:40.9 | 5ghyA-4ev4A:43.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GHY_A_CEDA301_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 6 / 12 | ALA A 120SER A 121SER A 176ASN A 178LYS A 282GLY A 284 | MER A 400 (-3.5A)MER A 400 (-1.3A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.0A)MER A 400 (-3.1A) | 0.30A | 5ghyA-4pprA:20.2 | 5ghyA-4pprA:23.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHY_B_CEDB301_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 7 / 12 | SER A 70SER A 130ASN A 132ASN A 170LYS A 234GLY A 236ALA A 237 | MER A 301 (-1.3A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.0A)MER A 301 (-4.2A) | 0.47A | 5ghyB-3bfgA:41.7 | 5ghyB-3bfgA:42.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHY_B_CEDB301_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | SER A 70SER A 130ASN A 132ASN A 170LYS A 234GLY A 236 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 (-3.0A)MER A 401 (-3.6A) | 0.48A | 5ghyB-4ev4A:40.9 | 5ghyB-4ev4A:43.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GHY_B_CEDB301_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 6 / 12 | ALA A 120SER A 121SER A 176ASN A 178LYS A 282GLY A 284 | MER A 400 (-3.5A)MER A 400 (-1.3A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.0A)MER A 400 (-3.1A) | 0.29A | 5ghyB-4pprA:20.3 | 5ghyB-4pprA:23.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHZ_A_CEDA301_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 8 / 11 | SER A 70SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236ALA A 237 | MER A 301 (-1.3A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A)MER A 301 (-4.2A) | 0.48A | 5ghzA-3bfgA:41.9 | 5ghzA-3bfgA:42.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHZ_A_CEDA301_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 7 / 11 | SER A 70SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A) | 0.47A | 5ghzA-4ev4A:40.9 | 5ghzA-4ev4A:43.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GHZ_A_CEDA301_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 7 / 11 | ALA A 120SER A 121SER A 176ASN A 178LYS A 282THR A 283GLY A 284 | MER A 400 (-3.5A)MER A 400 (-1.3A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.0A)MER A 400 (-3.6A)MER A 400 (-3.1A) | 0.31A | 5ghzA-4pprA:20.3 | 5ghzA-4pprA:23.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHZ_B_CEDB301_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 7 / 10 | SER A 70SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236 | MER A 301 (-1.3A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A) | 0.46A | 5ghzB-3bfgA:42.0 | 5ghzB-3bfgA:42.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHZ_B_CEDB301_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 7 / 10 | SER A 70SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A) | 0.47A | 5ghzB-4ev4A:41.0 | 5ghzB-4ev4A:43.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GHZ_B_CEDB301_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 7 / 10 | ALA A 120SER A 121SER A 176ASN A 178LYS A 282THR A 283GLY A 284 | MER A 400 (-3.5A)MER A 400 (-1.3A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.0A)MER A 400 (-3.6A)MER A 400 (-3.1A) | 0.31A | 5ghzB-4pprA:20.3 | 5ghzB-4pprA:23.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KMW_A_PNNA305_0 (BETA-LACTAMASETOHO-1) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 4 / 4 | ASN A 104PRO A 167ASN A 170ASP A 240 | MER A 301 ( 4.1A)NoneMER A 301 (-2.6A)None | 0.42A | 5kmwA-3bfgA:46.8 | 5kmwA-3bfgA:77.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YVN_A_ACTA305_0 (GLUTATHIONES-TRANSFERASEOMEGA-1) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 4 / 6 | LEU A 169LYS A 73LEU A 76LEU A 139 | NoneMER A 401 ( 4.4A)NoneNone | 1.08A | 5yvnA-4ev4A:undetectable | 5yvnA-4ev4A:20.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5Y_A_9F2A302_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 5 / 9 | PRO A 107TYR A 129THR A 215THR A 216ASP A 240 | NoneNoneNoneMER A 301 (-3.6A)None | 0.69A | 6b5yA-3bfgA:40.76b5yB-3bfgA:40.9 | 6b5yA-3bfgA:18.106b5yB-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5Y_B_9F2B400_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 8 / 12 | SER A 70SER A 130ASN A 170THR A 216LYS A 234THR A 235GLY A 236ASP A 240 | MER A 301 (-1.3A)MER A 301 (-2.6A)MER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A)None | 0.66A | 6b5yB-3bfgA:40.9 | 6b5yB-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5Y_B_9F2B400_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 9 / 12 | SER A 70SER A 130ASN A 170THR A 216ARG A 220LYS A 234THR A 235GLY A 236THR A 237 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A)MER A 401 (-3.7A) | 0.41A | 6b5yB-4ev4A:39.5 | 6b5yB-4ev4A:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5Y_B_9F2B400_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | SER A 130THR A 216ARG A 220THR A 235THR A 237GLY A 239 | MER A 401 (-2.8A)MER A 401 ( 3.9A)MER A 401 ( 3.9A)MER A 401 (-3.5A)MER A 401 (-3.7A)None | 0.81A | 6b5yB-4ev4A:39.5 | 6b5yB-4ev4A:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5Y_C_9F2C302_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 5 / 10 | PRO A 107TYR A 129THR A 215THR A 216ASP A 240 | NoneNoneNoneMER A 301 (-3.6A)None | 0.80A | 6b5yC-3bfgA:41.06b5yD-3bfgA:41.0 | 6b5yC-3bfgA:18.106b5yD-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5Y_D_9F2D400_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 8 / 12 | SER A 70SER A 130ASN A 170THR A 216LYS A 234THR A 235GLY A 236ASP A 240 | MER A 301 (-1.3A)MER A 301 (-2.6A)MER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A)None | 0.71A | 6b5yD-3bfgA:41.0 | 6b5yD-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5Y_D_9F2D400_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 8 / 12 | SER A 70SER A 130ASN A 170THR A 216LYS A 234THR A 235GLY A 236THR A 237 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A)MER A 401 (-3.7A) | 0.48A | 6b5yD-4ev4A:39.6 | 6b5yD-4ev4A:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5Y_D_9F2D400_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 5 / 12 | SER A 121SER A 176LYS A 282THR A 283GLY A 284 | MER A 400 (-1.3A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.6A)MER A 400 (-3.1A) | 0.48A | 6b5yD-4pprA:20.0 | 6b5yD-4pprA:13.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B68_A_9F2A302_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 5 / 9 | PRO A 107TYR A 129THR A 215THR A 216ASP A 240 | NoneNoneNoneMER A 301 (-3.6A)None | 0.68A | 6b68A-3bfgA:41.16b68B-3bfgA:41.2 | 6b68A-3bfgA:18.106b68B-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B68_B_9F2B301_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 8 / 12 | SER A 70SER A 130ASN A 170THR A 216LYS A 234THR A 235GLY A 236ASP A 240 | MER A 301 (-1.3A)MER A 301 (-2.6A)MER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A)None | 0.58A | 6b68B-3bfgA:41.2 | 6b68B-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B68_B_9F2B301_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 8 / 12 | SER A 70SER A 130ASN A 170THR A 216LYS A 234THR A 235GLY A 236THR A 237 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A)MER A 401 (-3.7A) | 0.34A | 6b68B-4ev4A:39.6 | 6b68B-4ev4A:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B68_B_9F2B301_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 5 / 12 | SER A 121SER A 176LYS A 282THR A 283GLY A 284 | MER A 400 (-1.3A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.6A)MER A 400 (-3.1A) | 0.27A | 6b68B-4pprA:20.1 | 6b68B-4pprA:13.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B68_C_9F2C302_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 5 / 10 | PRO A 107TYR A 129THR A 215THR A 216ASP A 240 | NoneNoneNoneMER A 301 (-3.6A)None | 0.76A | 6b68C-3bfgA:40.96b68D-3bfgA:41.0 | 6b68C-3bfgA:18.106b68D-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B68_D_9F2D400_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 7 / 12 | SER A 70SER A 130ASN A 170THR A 216LYS A 234GLY A 236ASP A 240 | MER A 301 (-1.3A)MER A 301 (-2.6A)MER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.0A)None | 0.64A | 6b68D-3bfgA:41.0 | 6b68D-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B68_D_9F2D400_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 8 / 12 | SER A 70SER A 130ASN A 170THR A 216ARG A 220LYS A 234GLY A 236THR A 237 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.6A)MER A 401 (-3.7A) | 0.42A | 6b68D-4ev4A:39.5 | 6b68D-4ev4A:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B69_A_9F2A302_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 5 / 9 | PRO A 107TYR A 129THR A 215THR A 216ASP A 240 | NoneNoneNoneMER A 301 (-3.6A)None | 0.72A | 6b69A-3bfgA:40.96b69B-3bfgA:41.0 | 6b69A-3bfgA:18.106b69B-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B69_B_9F2B301_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 9 / 12 | SER A 70SER A 130PRO A 167ASN A 170THR A 216LYS A 234THR A 235GLY A 236ASP A 240 | MER A 301 (-1.3A)MER A 301 (-2.6A)NoneMER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A)None | 0.55A | 6b69A-3bfgA:40.96b69B-3bfgA:41.0 | 6b69A-3bfgA:18.106b69B-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B69_B_9F2B301_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 8 / 12 | SER A 70SER A 130ASN A 170THR A 216LYS A 234THR A 235GLY A 236THR A 237 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A)MER A 401 (-3.7A) | 0.32A | 6b69A-4ev4A:39.46b69B-4ev4A:39.6 | 6b69A-4ev4A:18.106b69B-4ev4A:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B69_B_9F2B301_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 7 / 12 | SER A 70SER A 130PRO A 104THR A 216LYS A 234THR A 235THR A 237 | MER A 401 (-1.3A)MER A 401 (-2.8A)NoneMER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.7A) | 1.34A | 6b69A-4ev4A:39.46b69B-4ev4A:39.6 | 6b69A-4ev4A:18.106b69B-4ev4A:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B69_B_9F2B301_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 5 / 12 | SER A 121SER A 176LYS A 282THR A 283GLY A 284 | MER A 400 (-1.3A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.6A)MER A 400 (-3.1A) | 0.26A | 6b69A-4pprA:20.16b69B-4pprA:20.0 | 6b69A-4pprA:13.466b69B-4pprA:13.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B69_C_9F2C302_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 5 / 9 | PRO A 107TYR A 129THR A 215THR A 216ASP A 240 | NoneNoneNoneMER A 301 (-3.6A)None | 0.70A | 6b69C-3bfgA:40.96b69D-3bfgA:41.0 | 6b69C-3bfgA:18.106b69D-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B69_D_9F2D301_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 7 / 12 | SER A 70SER A 130ASN A 170THR A 216LYS A 234THR A 235GLY A 236 | MER A 301 (-1.3A)MER A 301 (-2.6A)MER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A) | 0.42A | 6b69D-3bfgA:41.0 | 6b69D-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B69_D_9F2D301_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 9 / 12 | SER A 70SER A 130ASN A 170THR A 216ARG A 220LYS A 234THR A 235GLY A 236THR A 237 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A)MER A 401 (-3.7A) | 0.33A | 6b69D-4ev4A:39.5 | 6b69D-4ev4A:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6A_A_9F2A302_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 5 / 9 | PRO A 107TYR A 129THR A 215THR A 216ASP A 240 | NoneNoneNoneMER A 301 (-3.6A)None | 0.76A | 6b6aA-3bfgA:40.86b6aB-3bfgA:41.1 | 6b6aA-3bfgA:18.106b6aB-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6A_B_9F2B301_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 8 / 12 | SER A 70SER A 130ASN A 170THR A 216LYS A 234THR A 235GLY A 236ASP A 240 | MER A 301 (-1.3A)MER A 301 (-2.6A)MER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A)None | 0.60A | 6b6aB-3bfgA:41.1 | 6b6aB-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6A_B_9F2B301_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 9 / 12 | SER A 70SER A 130ASN A 170THR A 216ARG A 220LYS A 234THR A 235GLY A 236THR A 237 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A)MER A 401 (-3.7A) | 0.37A | 6b6aB-4ev4A:39.4 | 6b6aB-4ev4A:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6A_C_9F2C302_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 5 / 9 | PRO A 107TYR A 129THR A 215THR A 216ASP A 240 | NoneNoneNoneMER A 301 (-3.6A)None | 0.71A | 6b6aC-3bfgA:40.86b6aD-3bfgA:41.1 | 6b6aC-3bfgA:18.106b6aD-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6A_D_9F2D301_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 7 / 12 | SER A 70SER A 130ASN A 170LYS A 234THR A 235GLY A 236ASP A 240 | MER A 301 (-1.3A)MER A 301 (-2.6A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A)None | 0.53A | 6b6aD-3bfgA:41.1 | 6b6aD-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6A_D_9F2D301_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 8 / 12 | SER A 70SER A 130ASN A 170ARG A 220LYS A 234THR A 235GLY A 236THR A 237 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A)MER A 401 (-3.7A) | 0.39A | 6b6aD-4ev4A:39.3 | 6b6aD-4ev4A:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6A_D_9F2D301_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 5 / 12 | SER A 121SER A 176LYS A 282THR A 283GLY A 284 | MER A 400 (-1.3A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.6A)MER A 400 (-3.1A) | 0.27A | 6b6aD-4pprA:19.8 | 6b6aD-4pprA:13.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6C_A_9F2A301_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 7 / 12 | SER A 70SER A 130PRO A 167ASN A 170LYS A 234THR A 235GLY A 236 | MER A 301 (-1.3A)MER A 301 (-2.6A)NoneMER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A) | 0.53A | 6b6cA-3bfgA:41.1 | 6b6cA-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6C_A_9F2A301_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 8 / 12 | SER A 70SER A 130ASN A 170ARG A 220LYS A 234THR A 235GLY A 236THR A 237 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A)MER A 401 (-3.7A) | 0.48A | 6b6cA-4ev4A:39.2 | 6b6cA-4ev4A:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6C_A_9F2A301_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 7 / 12 | SER A 70SER A 130PRO A 104ARG A 220LYS A 234THR A 235THR A 237 | MER A 401 (-1.3A)MER A 401 (-2.8A)NoneMER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.7A) | 1.29A | 6b6cA-4ev4A:39.2 | 6b6cA-4ev4A:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6C_A_9F2A301_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 5 / 12 | SER A 121SER A 176LYS A 282THR A 283GLY A 284 | MER A 400 (-1.3A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.6A)MER A 400 (-3.1A) | 0.37A | 6b6cA-4pprA:20.1 | 6b6cA-4pprA:13.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6D_A_9F2A302_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 6 / 12 | SER A 70ASN A 170THR A 216LYS A 234THR A 235GLY A 236 | MER A 301 (-1.3A)MER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A) | 0.46A | 6b6dA-3bfgA:40.7 | 6b6dA-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6D_A_9F2A302_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 6 / 12 | SER A 70SER A 130ASN A 170LYS A 234THR A 235GLY A 236 | MER A 301 (-1.3A)MER A 301 (-2.6A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A) | 0.68A | 6b6dA-3bfgA:40.7 | 6b6dA-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6D_A_9F2A302_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 8 / 12 | SER A 70SER A 130ASN A 170THR A 216LYS A 234THR A 235GLY A 236THR A 237 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A)MER A 401 (-3.7A) | 0.58A | 6b6dA-4ev4A:39.4 | 6b6dA-4ev4A:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6E_A_9F2A302_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 7 / 12 | SER A 70SER A 130ASN A 170THR A 216LYS A 234THR A 235GLY A 236 | MER A 301 (-1.3A)MER A 301 (-2.6A)MER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A) | 0.40A | 6b6eA-3bfgA:40.9 | 6b6eA-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6E_A_9F2A302_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 9 / 12 | SER A 70SER A 130ASN A 170THR A 216ARG A 220LYS A 234THR A 235GLY A 236THR A 237 | MER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A)MER A 401 (-3.7A) | 0.39A | 6b6eA-4ev4A:39.4 | 6b6eA-4ev4A:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6F_A_9F2A301_1 (BETA-LACTAMASE) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 9 / 12 | CSS A 69SER A 70SER A 130PRO A 167ASN A 170LYS A 234THR A 235GLY A 236ASP A 240 | MER A 301 (-4.6A)MER A 301 (-1.3A)MER A 301 (-2.6A)NoneMER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A)None | 0.56A | 6b6fA-3bfgA:40.7 | 6b6fA-3bfgA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6F_A_9F2A301_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 8 / 12 | CSS A 69SER A 70SER A 130ASN A 170LYS A 234THR A 235GLY A 236THR A 237 | NoneMER A 401 (-1.3A)MER A 401 (-2.8A)MER A 401 (-2.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A)MER A 401 (-3.7A) | 0.48A | 6b6fA-4ev4A:39.0 | 6b6fA-4ev4A:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6F_A_9F2A301_1 (BETA-LACTAMASE) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | SER A 70SER A 130PRO A 104LYS A 234THR A 235THR A 237 | MER A 401 (-1.3A)MER A 401 (-2.8A)NoneMER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.7A) | 1.43A | 6b6fA-4ev4A:39.0 | 6b6fA-4ev4A:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6F_A_9F2A301_1 (BETA-LACTAMASE) |
4ppr | PENICILLIN-BINDINGPROTEIN DACB1 (Mycobacteriumtuberculosis) | 5 / 12 | SER A 121SER A 176LYS A 282THR A 283GLY A 284 | MER A 400 (-1.3A)MER A 400 (-2.5A)MER A 400 (-3.0A)MER A 400 (-3.6A)MER A 400 (-3.1A) | 0.48A | 6b6fA-4pprA:20.0 | 6b6fA-4pprA:13.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6C79_A_CE3A301_1 (BETA-LACTAMASETOHO-1) |
3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) | 7 / 12 | ASN A 104SER A 130ASN A 132ASN A 170THR A 216LYS A 234GLY A 236 | MER A 301 ( 4.1A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.0A) | 0.38A | 6c79A-3bfgA:47.4 | 6c79A-3bfgA:72.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6C79_A_CE3A301_1 (BETA-LACTAMASETOHO-1) |
4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) | 6 / 12 | SER A 130ASN A 132ASN A 170THR A 216LYS A 234GLY A 236 | MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.6A) | 0.45A | 6c79A-4ev4A:42.3 | 6c79A-4ev4A:15.19 |